Literature DB >> 26152198

Ligand Residence Time at G-protein-Coupled Receptors-Why We Should Take Our Time To Study It.

C Hoffmann1, M Castro2, A Rinken2, R Leurs2, S J Hill2, H F Vischer2.   

Abstract

Over the past decade the kinetics of ligand binding to a receptor have received increasing interest. The concept of drug-target residence time is becoming an invaluable parameter for drug optimization. It holds great promise for drug development, and its optimization is thought to reduce off-target effects. The success of long-acting drugs like tiotropium support this hypothesis. Nonetheless, we know surprisingly little about the dynamics and the molecular detail of the drug binding process. Because protein dynamics and adaptation during the binding event will change the conformation of the protein, ligand binding will not be the static process that is often described. This can cause problems because simple mathematical models often fail to adequately describe the dynamics of the binding process. In this minireview we will discuss the current situation with an emphasis on G-protein-coupled receptors. These are important membrane protein drug targets that undergo conformational changes upon agonist binding to communicate signaling information across the plasma membrane of cells.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26152198     DOI: 10.1124/mol.115.099671

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  17 in total

Review 1.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 2.  Perspective: Implications of Ligand-Receptor Binding Kinetics for Therapeutic Targeting of G Protein-Coupled Receptors.

Authors:  Wijnand J C van der Velden; Laura H Heitman; Mette M Rosenkilde
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-18

Review 3.  New paradigms in GPCR drug discovery.

Authors:  Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2015-08-08       Impact factor: 5.858

4.  Exploring the Effect of Cyclization of Histamine H1 Receptor Antagonists on Ligand Binding Kinetics.

Authors:  Zhiyong Wang; Reggie Bosma; Sebastiaan Kuhne; Jelle van den Bor; Wrej Garabitian; Henry F Vischer; Maikel Wijtmans; Rob Leurs; Iwan J P de Esch
Journal:  ACS Omega       Date:  2021-05-07

5.  Non-equivalence of Key Positively Charged Residues of the Free Fatty Acid 2 Receptor in the Recognition and Function of Agonist Versus Antagonist Ligands.

Authors:  Eugenia Sergeev; Anders Højgaard Hansen; Sunil K Pandey; Amanda E MacKenzie; Brian D Hudson; Trond Ulven; Graeme Milligan
Journal:  J Biol Chem       Date:  2015-10-29       Impact factor: 5.157

6.  Mass spectrometry-based ligand binding assays on adenosine A1 and A2A receptors.

Authors:  A Massink; M Holzheimer; A Hölscher; J Louvel; D Guo; G Spijksma; T Hankemeier; A P IJzerman
Journal:  Purinergic Signal       Date:  2015-10-19       Impact factor: 3.765

7.  The Target Residence Time of Antihistamines Determines Their Antagonism of the G Protein-Coupled Histamine H1 Receptor.

Authors:  Reggie Bosma; Gesa Witt; Lea A I Vaas; Ivana Josimovic; Philip Gribbon; Henry F Vischer; Sheraz Gul; Rob Leurs
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

8.  Scintillation proximity assay (SPA) as a new approach to determine a ligand's kinetic profile. A case in point for the adenosine A1 receptor.

Authors:  Lizi Xia; Henk de Vries; Ad P IJzerman; Laura H Heitman
Journal:  Purinergic Signal       Date:  2015-12-09       Impact factor: 3.765

9.  Development of novel fluorescent histamine H1-receptor antagonists to study ligand-binding kinetics in living cells.

Authors:  Leigh A Stoddart; Andrea J Vernall; Monica Bouzo-Lorenzo; Reggie Bosma; Albert J Kooistra; Chris de Graaf; Henry F Vischer; Rob Leurs; Stephen J Briddon; Barrie Kellam; Stephen J Hill
Journal:  Sci Rep       Date:  2018-01-25       Impact factor: 4.379

10.  A two-state model for the kinetics of competitive radioligand binding.

Authors:  Dong Guo; Lambertus A Peletier; Lloyd Bridge; Wesley Keur; Henk de Vries; Annelien Zweemer; Laura H Heitman; Adriaan P IJzerman
Journal:  Br J Pharmacol       Date:  2018-04-17       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.